depression on semaglutide Study links and tirzepatide to fewer anxiety and diagnoses in obesity care Semaglutide Attenuates Anxious and Depressive-Like

Semaglutide is indicated, in combination with a reduced calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged 12 and older with obesity, and in adults with overweight plus at least one weight-related comorbid condition

(It is unclear when that will happen, but there is evidence it may not be far off: Novo Nordisk, which makes Wegovy and Ozempic using semaglutide, has recently increased supply of most dosages of the meds in the US.) The cost of drugs does not factor into whether they are in official shortage or not, but the affordability of these medications is directly connected to how accessible many patients find them

The risk increases when antibiotics need high peak concentrations to work optimally, such as certain fluoroquinolones used for serious infections

Neither outcome is guaranteed